These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 16083700)
1. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Shaheen NJ; Green B; Medapalli RK; Mitchell KL; Wei JT; Schmitz SM; West LM; Brown A; Noble M; Sultan S; Provenzale D Gastroenterology; 2005 Aug; 129(2):429-36. PubMed ID: 16083700 [TBL] [Abstract][Full Text] [Related]
2. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761 [TBL] [Abstract][Full Text] [Related]
3. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768 [TBL] [Abstract][Full Text] [Related]
4. Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Wong T; Tian J; Nagar AB Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324 [TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Provenzale D; Schmitt C; Wong JB Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526 [TBL] [Abstract][Full Text] [Related]
7. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
9. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Achkar E; Carey W Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739 [TBL] [Abstract][Full Text] [Related]
10. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862 [TBL] [Abstract][Full Text] [Related]
11. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma and Barrett's esophagus. An overrated risk? Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881 [TBL] [Abstract][Full Text] [Related]
13. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
14. Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low. Kruijshaar ME; Siersema PD; Janssens AC; Kerkhof M; Steyerberg EW; Essink-Bot ML; Gastrointest Endosc; 2007 Jan; 65(1):26-30. PubMed ID: 17185076 [TBL] [Abstract][Full Text] [Related]
15. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study. Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082 [TBL] [Abstract][Full Text] [Related]
16. A surveillance programme for Barrett's oesophagus in a UK general hospital. Olithselvan A; Gorard DA; McIntyre AS Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694 [TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus surveillance: When, how often, does it work? Katona BW; Falk GW Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494 [TBL] [Abstract][Full Text] [Related]
18. New developments in the endoscopic surveillance of Barrett's oesophagus. Bergman JJ; Tytgat GN Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i38-42. PubMed ID: 15711007 [TBL] [Abstract][Full Text] [Related]
19. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma? Quera R; O'Sullivan K; Quigley EM Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424 [TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Rugge M; Zaninotto G; Parente P; Zanatta L; Cavallin F; Germanà B; Macrì E; Galliani E; Iuzzolino P; Ferrara F; Marin R; Nisi E; Iaderosa G; Deboni M; Bellumat A; Valiante F; Florea G; Della Libera D; Benini M; Bortesi L; Meggio A; Zorzi MG; Depretis G; Miori G; Morelli L; Cataudella G; d'Amore ES; Franceschetti I; Bozzola L; Paternello E; Antonini C; Di Mario F; Dal Bò N; Furlanetto A; Norberto L; Polese L; Iommarini S; Farinati F; Battaglia G; Diamantis G; Realdon S; Guido E; Mastropaolo G; Canova D; Guerini A; Franceschi M; Zirillo M Ann Surg; 2012 Nov; 256(5):788-94; discussion 794-5. PubMed ID: 23095623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]